Management of chronic hepatitis B patients: Efficacy & limitation of nucleos(t)ide analogues
2011
Managing Chronic Hepatitis B: Effectiveness and Limitations of Nucleos(t)ide Analogues
Commentary
Author Information
Author(s): Inoue Jun, Ueno Yoshiyuki, Shimosegawa Tooru
Primary Institution: Tohoku University Graduate School of Medicine
Conclusion
Nucleos(t)ide analogues can improve liver health in chronic hepatitis B patients, but their effectiveness is often limited by drug resistance.
Supporting Evidence
- Nucleos(t)ide analogues like lamivudine and adefovir can improve liver health.
- Drug-resistant mutations can occur with long-term use of these medications.
- Entecavir and tenofovir are recommended for treatment-naïve patients due to lower resistance rates.
Takeaway
This study talks about how some medicines can help people with a liver virus, but sometimes the virus can become strong and not go away.
Limitations
The sample size is small and the treatment duration was short.
Want to read the original?
Access the complete publication on the publisher's website